Desktop Site
|
24 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,852.94
+114.49
+0.16 %
Corporate Announcement
Security Code
506197
Company
BLISS GVS PHARMA LTD.
Exchange Received Time
11/11/2019 21:28:15
Exchange Disseminated Time
11/11/2019 21:28:17
Time Taken
00:00:02
Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2019. |
11/11/19 21:28
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board Meeting of the Company was held today i.e. on Monday, November 11, 2019 at the registered office of the Company. The Board has considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2019.
A copy of unaudited financial results along with the Limited Review Report of the Auditor of the Company are enclosed herewith as Annexure-I.
The meeting of the Board of Directors commenced at 6.30 p.m. and concluded at 9.15 p.m.
Kindly take the same on record.
Attachment
<< Back
Recently Viewed